Anti-tuberculosis neolignans from Piper regnellii

作者：Scodro R B L; Pires C T A; Carrara V S; Lemos C O T; Cardozo Filho L; Souza V A; Correa A G; Siqueira V L D; Lonardoni M V C; Cardoso R F; Cortez D A G^*

来源：Phytomedicine, 2013, 20(7): 600-604.

DOI：10.1016/j.phymed.2013.01.005

• Tuberculosis
• Mycobacterium tuberculosis
• Piper regnellii
• Neolignans
• REMA

The present study determined the anti-Mycobacterium tuberculosis activities of supercritical CO2 extracts, neolignans eupomatenoid-5 (1), conocarpan (4) and eupomatenoid-3 (7) and their derivatives (2, 3, 5, 6, and 8) from Piper regnellii, as well as their cytotoxicities. The supercritical CO2 extract from leaves was purified by chromatographic methods, yielding compounds (1), (4) and (7), which were identified by H-1 NMR and comparison with literature data. Anti-M. tuberculosis activity (H(37)Rv and clinical isolates) was evaluated using a resazurin microtiter assay plate (REMA) to determine the MIC. The cytotoxicity assay was carried out in macrophages J774G.8 by sulforhodamine B colorimetric assay. The supercritical CO2 extracts from leaves and stems, and compound (4) showed activity against M. tuberculosis (MIC 15.6 mu g/ml). Compound (1) showed the best activity (MIC 1.9 mu g/ml), with good SI. Compounds (7) and (8) showed low activity against M. tuberculosis H(37)Rv. The derivative compounds did not show increased anti-M. tuberculosis activity. This is the first report, to our knowledge, to describe neolignans from P. regnellii with activity against M. tuberculosis, and compound (1) is a potential candidate for future antituberculosis drugs.

• 出版日期2013-5-15